Abnova Taiwan Corp - Asset Resilience Ratio

Latest as of December 2025: 0.07%

Abnova Taiwan Corp (4133) has an Asset Resilience Ratio of 0.07% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check strategic asset allocation of Abnova Taiwan Corp to assess the company's strategic physical and investment asset allocation.

Liquid Assets

NT$880.00K

≈ $27.72K USD Cash + Short-term Investments

Total Assets

NT$1.33 Billion

≈ $41.82 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2008–2025)

This chart shows how Abnova Taiwan Corp's Asset Resilience Ratio has changed over time. See Abnova Taiwan Corp balance sheet independence to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Abnova Taiwan Corp's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Abnova Taiwan Corp (4133) market capitalisation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	NT$0.00	0%
Short-term Investments	NT$880.00K	0.07%
Total Liquid Assets	NT$880.00K	0.07%

Asset Resilience Insights

Limited Liquidity: Abnova Taiwan Corp maintains only 0.07% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Abnova Taiwan Corp Industry Peers by Asset Resilience Ratio

Compare Abnova Taiwan Corp's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Biomarin Pharmaceutical Inc NASDAQ:BMRN	Biotechnology	0.00%
Cyclacel Pharmaceuticals Inc NASDAQ:CYCC	Biotechnology	-55.36%
Krystal Biotech Inc NASDAQ:KRYS	Biotechnology	23.06%
Verona Pharma PLC ADR NASDAQ:VRNA	Biotechnology	0.00%
Centessa Pharmaceuticals PLC ADR NASDAQ:CNTA	Biotechnology	33.37%
Beijing Tiantan Biological Products Corp Ltd SHG:600161	Biotechnology	8.08%
Hebei Changshan Biochem Pharma SHE:300255	Biotechnology	-0.03%
BB Biotech AG SW:BION	Biotechnology	0.05%

Annual Asset Resilience Ratio for Abnova Taiwan Corp (2008–2025)

The table below shows the annual Asset Resilience Ratio data for Abnova Taiwan Corp.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	0.07%	NT$880.00K ≈ $27.72K	NT$1.33 Billion ≈ $41.82 Million	+0.00pp
2022-12-31	0.06%	NT$849.00K ≈ $26.75K	NT$1.37 Billion ≈ $43.31 Million	+0.02pp
2021-12-31	0.04%	NT$545.00K ≈ $17.17K	NT$1.28 Billion ≈ $40.42 Million	+0.00pp
2020-12-31	0.04%	NT$543.00K ≈ $17.11K	NT$1.29 Billion ≈ $40.79 Million	0.00pp
2019-12-31	0.04%	NT$540.00K ≈ $17.01K	NT$1.26 Billion ≈ $39.82 Million	+0.00pp
2018-12-31	0.04%	NT$537.00K ≈ $16.92K	NT$1.29 Billion ≈ $40.80 Million	+0.00pp
2017-12-31	0.04%	NT$533.00K ≈ $16.79K	NT$1.30 Billion ≈ $41.08 Million	-5.50pp
2016-12-31	5.54%	NT$69.11 Million ≈ $2.18 Million	NT$1.25 Billion ≈ $39.33 Million	-10.15pp
2015-12-31	15.69%	NT$195.97 Million ≈ $6.17 Million	NT$1.25 Billion ≈ $39.35 Million	+15.65pp
2014-12-31	0.04%	NT$522.00K ≈ $16.45K	NT$1.31 Billion ≈ $41.21 Million	0.00pp
2013-12-31	0.04%	NT$517.00K ≈ $16.29K	NT$1.29 Billion ≈ $40.49 Million	+0.00pp
2012-12-31	0.04%	NT$513.00K ≈ $16.16K	NT$1.29 Billion ≈ $40.71 Million	+0.00pp
2011-12-31	0.04%	NT$508.00K ≈ $16.00K	NT$1.36 Billion ≈ $42.70 Million	0.00pp
2010-12-31	0.04%	NT$504.00K ≈ $15.88K	NT$1.33 Billion ≈ $42.03 Million	-1.09pp
2009-12-31	1.13%	NT$14.72 Million ≈ $463.73K	NT$1.31 Billion ≈ $41.13 Million	-0.07pp
2008-12-31	1.20%	NT$10.26 Million ≈ $323.21K	NT$857.02 Million ≈ $27.00 Million	--

pp = percentage points

About Abnova Taiwan Corp

TW:4133 Taiwan Biotechnology

Market Cap

$39.49 Million

NT$1.25 Billion TWD

Market Cap Rank

#22820 Global

#1427 in Taiwan

Share Price

NT$20.70

Change (1 day)

+0.49%

52-Week Range

NT$20.55 - NT$29.00

All Time High

NT$149.53